Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000247930

Medchemexpress LLC Ruboxistaurin mesylate | 192050-59-2 | 99.9% | 564.65 g·mol⁻1 | C29H32N4O6S | 1 MG
SDP

Catalog No. 5000247930
Encompass_Preferred

Ruboxistaurin mesylate is an orally active, selective ATP-competitive inhibitor of protein kinase C beta (PKCβ) used in research on diabetic vascular complications, retinal microcirculation, and cardiac models. It is supplied as an orange-red solid with high purity and is commonly prepared in DMSO for in vitro assays.

  • Orally active, selective PKCβ inhibitor.
  • High purity (≈99.9%) suitable for biochemical and cell-based assays.
  • Molecular weight 564.65 g·mol⁻1; formula C29H32N4O6S.
  • Soluble in DMSO at 50 mg/mL; may require ultrasonication.
  • Store sealed at 4°C; in solution store at -80°C for long-term stability.

Catalog No. 50-002-47930 Supplier Medchemexpress LLC Supplier No. HY10195A1MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Ruboxistaurin mesylate is an orally active, selective ATP-competitive inhibitor of protein kinase C beta (PKCβ) used in research on diabetic vascular complications, retinal microcirculation, and cardiac models. It is supplied as an orange-red solid with high purity and is commonly prepared in DMSO for in vitro assays.

  • Orally active, selective PKCβ inhibitor.
  • High purity (≈99.9%) suitable for biochemical and cell-based assays.
  • Molecular weight 564.65 g·mol⁻1; formula C29H32N4O6S.
  • Soluble in DMSO at 50 mg/mL; may require ultrasonication.
  • Store sealed at 4°C; in solution store at -80°C for long-term stability.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.